BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 15450843)

  • 21. Extended multiorgan resection for T4 gastric carcinoma: 25-year experience.
    Carboni F; Lepiane P; Santoro R; Lorusso R; Mancini P; Sperduti I; Carlini M; Santoro E
    J Surg Oncol; 2005 May; 90(2):95-100. PubMed ID: 15844189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of total gastrectomy with extended lymphadenectomy for gastric cancer in elderly patients.
    Otsuji E; Fujiyama J; Takagi T; Ito T; Kuriu Y; Toma A; Okamoto K; Hagiwara A; Yamagishi H
    J Surg Oncol; 2005 Sep; 91(4):232-6. PubMed ID: 16121342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?
    Lim S; Muhs BE; Marcus SG; Newman E; Berman RS; Hiotis SP
    J Surg Oncol; 2007 Feb; 95(2):118-22. PubMed ID: 17262741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Videolaparoscopic total and subtotal gastrectomy with extended lymph node dissection for gastric cancer.
    Huscher CG; Mingoli A; Sgarzini G; Sansonetti A; Lirici MM; Napolitano C; Piro F
    Am J Surg; 2004 Dec; 188(6):728-35. PubMed ID: 15619491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Multivariate prognostic analysis in gastric carcinoma patients after radical operation].
    Zhan YQ; Sun XW; Li W; Chen YB; Xu L; Guan YX; Li YF; Xu DZ
    Ai Zheng; 2005 May; 24(5):596-9. PubMed ID: 15890105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database.
    Smith DD; Schwarz RR; Schwarz RE
    J Clin Oncol; 2005 Oct; 23(28):7114-24. PubMed ID: 16192595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastric cancer: surgical management and prognosis.
    Arak A; Lehtola J; Mäkelä J; Tuominen H
    Ann Chir Gynaecol; 1996; 85(4):293-8. PubMed ID: 9014057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of surgical results of D2 versus D3 gastrectomy (para-aortic lymph node dissection) for advanced gastric carcinoma: a multi-institutional study.
    Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Nagahori Y; Hosoi H; Takahashi M; Kito F; Shimada H
    Ann Surg Oncol; 2006 May; 13(5):659-67. PubMed ID: 16538414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.
    Cho BC; Jeung HC; Choi HJ; Rha SY; Hyung WJ; Cheong JH; Noh SH; Chung HC
    J Surg Oncol; 2007 May; 95(6):461-8. PubMed ID: 17192913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of stage migration on the comparison of surgical outcomes between D2 gastrectomy and D3 gastrectomy (para-aortic lymph node dissection): a multi-institutional retrospective study.
    Kunisaki C; Takahashi M; Fukushima T; Nagahori Y; Akiyama H; Makino H; Otsuka Y; Ono HA; Kosaka T; Takagawa R; Shimada H
    Am J Surg; 2008 Sep; 196(3):358-63. PubMed ID: 18466868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Survival rate for gastric carcinoma in relation to tumor site and stage (author's transl)].
    Husemann B
    MMW Munch Med Wochenschr; 1980 Aug; 122(32-33):1123-6. PubMed ID: 6258059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in surgical treatment have improved the survival of patients with gastric carcinoma.
    Otsuji E; Yamaguchi T; Sawai K; Hagiwara A; Taniguchi H; Takahashi T
    Cancer; 1998 Apr; 82(7):1233-7. PubMed ID: 9529013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of super-extended (D3) lymphadenectomy in gastric cancer surgery.
    Laterza E; Giacopuzzi S; Minicozzi A; Saladino E; de Manzoni G
    Ann Ital Chir; 2009; 80(2):101-6. PubMed ID: 19681290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment strategy for the type IV gastric cancer--from the standpoint of the surgery].
    Nashimoto A; Yabusaki H; Nakagawa S
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):983-7. PubMed ID: 17637531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
    Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
    Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Radical surgery in stomach cancer].
    D'Amico DF; Ranzato R
    Chir Ital; 1998; 50(5-6):9-14. PubMed ID: 10392188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical outcome in patients with gastric adenocarcinoma in the upper third of the stomach.
    Kunisaki C; Shimada H; Nomura M; Matsuda G; Otsuka Y; Ono H; Akiyama H
    Surgery; 2005 Feb; 137(2):165-71. PubMed ID: 15674196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pretreatment anemia is associated with poorer survival in patients with stage I and II gastric cancer.
    Shen JG; Cheong JH; Hyung WJ; Kim J; Choi SH; Noh SH
    J Surg Oncol; 2005 Aug; 91(2):126-30. PubMed ID: 16028285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical treatment of Borrmann type IV gastric carcinoma: relevance of lymphadenectomy in improving survival.
    Kodera Y; Yamamura Y; Torii A; Uesaka K; Hirai T; Yasui K; Morimoto T; Kato T; Kito T
    J Am Coll Surg; 1996 Nov; 183(5):480-5. PubMed ID: 8912617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment methods for scirrhous carcinoma of the stomach--with special reference to total gastrectomy and chemotherapy in early postoperative period].
    Nyumura T; Nabeya K; Hamakubo S; Higashino K
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1262-8. PubMed ID: 2837986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.